{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:09:59Z","timestamp":1783901399741,"version":"3.55.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003645","name":"National Cancer Center","doi-asserted-by":"publisher","award":["2510800"],"award-info":[{"award-number":["2510800"]}],"id":[{"id":"10.13039\/501100003645","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-52309-w","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T14:26:53Z","timestamp":1778596013000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Plasma acylcarnitine dysregulation associated with CPT1-mediated metabolism contributes to oral carcinogenesis"],"prefix":"10.1038","volume":"16","author":[{"given":"Yeon-Hee","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Weon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo Yong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heesun","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi Kyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"52309_CR1","doi-asserted-by":"publisher","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 236. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","DOI":"10.3322\/caac.21660"},{"key":"52309_CR2","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1200\/JCO.2015.61.2929","volume":"33","author":"SB Chinn","year":"2015","unstructured":"Chinn, S. B. & Myers, J. N. Oral cavity carcinoma: current management, controversies, and future directions. J. Clin. Oncol. 33, 3269. https:\/\/doi.org\/10.1200\/JCO.2015.61.2929 (2015).","journal-title":"J. Clin. Oncol."},{"key":"52309_CR3","doi-asserted-by":"publisher","first-page":"e0266346","DOI":"10.1371\/journal.pone.0266346","volume":"17","author":"RF Ribeiro-Rotta","year":"2022","unstructured":"Ribeiro-Rotta, R. F. et al. The cost of oral cancer: a systematic review. PLoS One. 17, e0266346. https:\/\/doi.org\/10.1371\/journal.pone.0266346 (2022).","journal-title":"PLoS One"},{"key":"52309_CR4","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.3390\/diagnostics11071287","volume":"11","author":"YF Su","year":"2021","unstructured":"Su, Y. F. et al. Current insights into oral cancer diagnostics. Diagnostics 11, 1287. https:\/\/doi.org\/10.3390\/diagnostics11071287 (2021).","journal-title":"Diagnostics"},{"key":"52309_CR5","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1177\/0022034521101479","volume":"100","author":"S Warnakulasuriya","year":"2021","unstructured":"Warnakulasuriya, S. & Kerr, A. Oral cancer screening: past, present, and future. J. Dent. Res. 100, 1313\u20131320. https:\/\/doi.org\/10.1177\/0022034521101479 (2021).","journal-title":"J. Dent. Res."},{"key":"52309_CR6","doi-asserted-by":"publisher","first-page":"e0218246","DOI":"10.1371\/journal.pone.0218246","volume":"14","author":"L Halczy-Kowalik","year":"2019","unstructured":"Halczy-Kowalik, L. et al. Fatty acids distribution and content in oral squamous cell carcinoma tissue and its adjacent microenvironment. PLoS One. 14, e0218246. https:\/\/doi.org\/10.1371\/journal.pone.0218246 (2019).","journal-title":"PLoS One"},{"key":"52309_CR7","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.3390\/pharmaceutics14061303","volume":"14","author":"C Navarro","year":"2022","unstructured":"Navarro, C. et al. Metabolic reprogramming in cancer cells: emerging molecular mechanisms and novel therapeutic approaches. Pharmaceutics 14, 1303. https:\/\/doi.org\/10.3390\/pharmaceutics14061303 (2022).","journal-title":"Pharmaceutics"},{"key":"52309_CR8","doi-asserted-by":"publisher","first-page":"e2003782","DOI":"10.1371\/journal.pbio.2003782","volume":"16","author":"CH Yao","year":"2018","unstructured":"Yao, C. H. et al. Identifying off-target effects of etomoxir reveals that carnitine palmitoyltransferase I is essential for cancer cell proliferation independent of \u03b2-oxidation. PLoS Biol. 16, e2003782. https:\/\/doi.org\/10.1371\/journal.pbio.2003782 (2018).","journal-title":"PLoS Biol."},{"key":"52309_CR9","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/s41419-020-02936-6","volume":"11","author":"X Xiong","year":"2020","unstructured":"Xiong, X. et al. Upregulation of CPT1A is essential for the tumor-promoting effect of adipocytes in colon cancer. Cell Death Dis. 11, 736. https:\/\/doi.org\/10.1038\/s41419-020-02936-6 (2020).","journal-title":"Cell Death Dis."},{"key":"52309_CR10","first-page":"2477","volume":"11","author":"J Wang","year":"2021","unstructured":"Wang, J., Xiang, H., Lu, Y., Wu, T. & Ji, G. The role and therapeutic implication of CPTs in fatty acid oxidation and cancers progression. Am. J. Cancer Res. 11, 2477 (2021).","journal-title":"Am. J. Cancer Res."},{"key":"52309_CR11","doi-asserted-by":"publisher","unstructured":"Wu, L. et al. The role of serum acylcarnitine profiling for the detection of multiple solid tumors in humans. Heliyon 10, 2563. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e23867 (2024).","DOI":"10.1016\/j.heliyon.2023.e23867"},{"key":"52309_CR12","doi-asserted-by":"publisher","first-page":"92324","DOI":"10.18632\/oncotarget.21289","volume":"8","author":"L Wang","year":"2017","unstructured":"Wang, L. et al. Plasma lipid profiling and diagnostic biomarkers for oral squamous cell carcinoma. Oncotarget 8, 92324. https:\/\/doi.org\/10.18632\/oncotarget.21289 (2017).","journal-title":"Oncotarget"},{"key":"52309_CR13","doi-asserted-by":"publisher","first-page":"e20210071","DOI":"10.1002\/ntls.20210071","volume":"2","author":"X Yang","year":"2022","unstructured":"Yang, X. et al. Big cohort metabolomic profiling of serum for oral squamous cell carcinoma screening and diagnosis. Nat. Sci. 2, e20210071. https:\/\/doi.org\/10.1002\/ntls.20210071 (2022).","journal-title":"Nat. Sci."},{"key":"52309_CR14","doi-asserted-by":"publisher","first-page":"8588","DOI":"10.1038\/s41598-023-34808-2","volume":"13","author":"GM Polachini","year":"2023","unstructured":"Polachini, G. M. et al. Plasma metabolomics of oral squamous cell carcinomas based on NMR and MS approaches provides biomarker identification and survival prediction. Sci. Rep. 13, 8588. https:\/\/doi.org\/10.1038\/s41598-023-34808-2 (2023).","journal-title":"Sci. Rep."},{"key":"52309_CR15","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s40364-023-00507-3","volume":"11","author":"W Wang","year":"2023","unstructured":"Wang, W. et al. Cancer metabolites: promising biomarkers for cancer liquid biopsy. Biomark. Res. 11, 66. https:\/\/doi.org\/10.1186\/s40364-023-00507-3 (2023).","journal-title":"Biomark. Res."},{"key":"52309_CR16","doi-asserted-by":"publisher","first-page":"1305684","DOI":"10.3389\/fonc.2024.1305684","volume":"14","author":"Z Hu","year":"2024","unstructured":"Hu, Z. et al. The role of blood metabolites in oral cancer: insights from a Mendelian randomization approach. Front. Oncol. 14, 1305684. https:\/\/doi.org\/10.3389\/fonc.2024.1305684 (2024).","journal-title":"Front. Oncol."},{"key":"52309_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11306-019-1483-8","volume":"15","author":"X Chen","year":"2019","unstructured":"Chen, X. & Yu, D. Metabolomics study of oral cancers. Metabolomics 15, 1\u201315. https:\/\/doi.org\/10.1007\/s11306-019-1483-8 (2019).","journal-title":"Metabolomics"},{"key":"52309_CR18","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.1038\/s41467-021-22756-2","volume":"12","author":"X Mi","year":"2021","unstructured":"Mi, X., Zou, B., Zou, F. & Hu, J. Permutation-based identification of important biomarkers for complex diseases via machine learning models. Nat. Commun. 12, 3008. https:\/\/doi.org\/10.1038\/s41467-021-22756-2 (2021).","journal-title":"Nat. Commun."},{"key":"52309_CR19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/s1470-2045(11)70318-7","volume":"13","author":"R Pirker","year":"2012","unstructured":"Pirker, R. et al. EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study. Lancet Oncol. 13, 33\u201342. https:\/\/doi.org\/10.1016\/s1470-2045(11)70318-7 (2012).","journal-title":"Lancet Oncol."},{"key":"52309_CR20","doi-asserted-by":"publisher","first-page":"102130","DOI":"10.1016\/j.aei.2023.102130","volume":"58","author":"L Li","year":"2023","unstructured":"Li, L. et al. A LightGBM-based strategy to predict tunnel rockmass class from TBM construction data for building control. Adv. Eng. Inf. 58, 102130. https:\/\/doi.org\/10.1016\/j.aei.2023.102130 (2023).","journal-title":"Adv. Eng. Inf."},{"key":"52309_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12920-020-00826-6","volume":"13","author":"A Acharjee","year":"2020","unstructured":"Acharjee, A., Larkman, J., Xu, Y., Cardoso, V. R. & Gkoutos, G. V. A random forest based biomarker discovery and power analysis framework for diagnostics research. BMC Med. Genomics. 13, 1\u201314. https:\/\/doi.org\/10.1186\/s12920-020-00826-6 (2020).","journal-title":"BMC Med. Genomics"},{"key":"52309_CR22","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ymgme.2018.06.012","volume":"125","author":"TN Tarasenko","year":"2018","unstructured":"Tarasenko, T. N., Cusmano-Ozog, K. & McGuire, P. J. Tissue acylcarnitine status in a mouse model of mitochondrial \u03b2-oxidation deficiency during metabolic decompensation due to influenza virus infection. Mol. Genet. Metab. 125, 144\u2013152. https:\/\/doi.org\/10.1016\/j.ymgme.2018.06.012 (2018).","journal-title":"Mol. Genet. Metab."},{"key":"52309_CR23","doi-asserted-by":"publisher","first-page":"871","DOI":"10.3390\/cancers14040871","volume":"14","author":"Z Zhelev","year":"2022","unstructured":"Zhelev, Z. et al. Over-reduced state of mitochondria as a trigger of \u03b2-oxidation shuttle in cancer cells. Cancers 14, 871. https:\/\/doi.org\/10.3390\/cancers14040871 (2022).","journal-title":"Cancers"},{"key":"52309_CR24","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1194\/jlr.M085613","volume":"59","author":"KY Peng","year":"2018","unstructured":"Peng, K. Y. et al. Mitochondrial dysfunction-related lipid changes occur in nonalcoholic fatty liver disease progression. J. Lipid Res. 59, 1977\u20131986. https:\/\/doi.org\/10.1194\/jlr.M085613 (2018).","journal-title":"J. Lipid Res."},{"key":"52309_CR25","doi-asserted-by":"publisher","first-page":"e0225129","DOI":"10.1371\/journal.pone.0225129","volume":"14","author":"J Park","year":"2019","unstructured":"Park, J., Shin, Y., Kim, T. H., Kim, D. H. & Lee, A. Plasma metabolites as possible biomarkers for diagnosis of breast cancer. PLoS One. 14, e0225129. https:\/\/doi.org\/10.1371\/journal.pone.0225129 (2019).","journal-title":"PLoS One"},{"key":"52309_CR26","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.3390\/nu16091265","volume":"16","author":"YH Kim","year":"2024","unstructured":"Kim, Y. H., Chung, J. S., Lee, H. H., Park, J. H. & Kim, M. K. Influence of dietary polyunsaturated fatty acid intake on potential lipid metabolite diagnostic markers in renal cell carcinoma: a case-control study. Nutrients 16, 1265. https:\/\/doi.org\/10.3390\/nu16091265 (2024).","journal-title":"Nutrients"},{"key":"52309_CR27","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41419-022-04730-y","volume":"13","author":"M Tang","year":"2022","unstructured":"Tang, M. et al. CPT1A-mediated fatty acid oxidation promotes cell proliferation via nucleoside metabolism in nasopharyngeal carcinoma. Cell. Death Dis. 13, 331. https:\/\/doi.org\/10.1038\/s41419-022-04730-y (2022).","journal-title":"Cell. Death Dis."},{"key":"52309_CR28","doi-asserted-by":"publisher","first-page":"1271505","DOI":"10.3389\/fonc.2023.1271505","volume":"13","author":"J Liang","year":"2023","unstructured":"Liang, J. et al. Lipid metabolism reprogramming in head and neck cancer. Front. Oncol. 13, 1271505. https:\/\/doi.org\/10.3389\/fonc.2023.1271505 (2023).","journal-title":"Front. Oncol."},{"key":"52309_CR29","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41392-024-01772-w","volume":"9","author":"L Ma","year":"2024","unstructured":"Ma, L. et al. Targeting carnitine palmitoyl transferase 1A (CPT1A) induces ferroptosis and synergizes with immunotherapy in lung cancer. Signal. Transduct. Target. Ther. 9, 64. https:\/\/doi.org\/10.1038\/s41392-024-01772-w (2024).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"52309_CR30","doi-asserted-by":"publisher","first-page":"e97330","DOI":"10.1371\/journal.pone.0097330","volume":"9","author":"S Li","year":"2014","unstructured":"Li, S. et al. High metastaticgastric and breast cancer cells consume oleic acid in an AMPK dependent manner. PLoS One. 9, e97330. https:\/\/doi.org\/10.1371\/journal.pone.0097330 (2014).","journal-title":"PLoS One"},{"key":"52309_CR31","doi-asserted-by":"publisher","first-page":"6302","DOI":"10.3390\/cancers13246302","volume":"13","author":"L Rios-Colon","year":"2021","unstructured":"Rios-Colon, L. et al. Carnitine palmitoyltransferase 1 regulates prostate cancer growth under hypoxia. Cancers 13, 6302. https:\/\/doi.org\/10.3390\/cancers13246302 (2021).","journal-title":"Cancers"},{"key":"52309_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2049-3002-2-13","volume":"2","author":"D Roy","year":"2014","unstructured":"Roy, D. et al. Loss of HSulf-1 promotes altered lipid metabolism in ovarian cancer. Cancer Metab. 2, 1\u201317. https:\/\/doi.org\/10.1186\/2049-3002-2-13 (2014).","journal-title":"Cancer Metab."},{"key":"52309_CR33","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1038\/ng.3073","volume":"46","author":"ML Gatza","year":"2014","unstructured":"Gatza, M. L., Silva, G. O., Parker, J. S., Fan, C. & Perou, C. M. An integrated genomics approach identifies drivers of proliferation in luminal-subtype human breast cancer. Nat. Genet. 46, 1051\u20131059. https:\/\/doi.org\/10.1038\/ng.3073 (2014).","journal-title":"Nat. Genet."},{"key":"52309_CR34","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.canlet.2018.08.006","volume":"435","author":"Y Ma","year":"2018","unstructured":"Ma, Y. et al. Fatty acid oxidation: an emerging facet of metabolic transformation in cancer. Cancer Lett. 435, 92\u2013100. https:\/\/doi.org\/10.1016\/j.canlet.2018.08.006 (2018).","journal-title":"Cancer Lett."},{"key":"52309_CR35","doi-asserted-by":"publisher","unstructured":"Farahzadi, R. et al. Clinical significance of carnitine in the treatment of cancer: from traffic to the regulation. Oxid. Med. Cell. Longev. 2023, 9328344. https:\/\/doi.org\/10.1155\/2023\/9328344 (2023).","DOI":"10.1155\/2023\/9328344"},{"key":"52309_CR36","doi-asserted-by":"publisher","first-page":"10890","DOI":"10.3390\/ijms252010890","volume":"25","author":"Z Praveen","year":"2024","unstructured":"Praveen, Z. et al. Oral microbiome and CPT1A function in fatty acid metabolism in oral cancer. Int. J. Mol. Sci. 25, 10890. https:\/\/doi.org\/10.3390\/ijms252010890 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"52309_CR37","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s41419-018-0313-7","volume":"9","author":"MAB Melone","year":"2018","unstructured":"Melone, M. A. B. et al. The carnitine system and cancer metabolic plasticity. Cell. Death Dis. 9, 228. https:\/\/doi.org\/10.1038\/s41419-018-0313-7 (2018).","journal-title":"Cell. Death Dis."},{"key":"52309_CR38","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1002\/hep.28415","volume":"63","author":"MD Wang","year":"2016","unstructured":"Wang, M. D. et al. Acetyl-coenzyme A carboxylase alpha promotion of glucose\u2010mediated fatty acid synthesis enhances survival of hepatocellular carcinoma in mice and patients. Hepatology 63, 1272\u20131286. https:\/\/doi.org\/10.1002\/hep.28415 (2016).","journal-title":"Hepatology"},{"key":"52309_CR39","doi-asserted-by":"publisher","first-page":"165720","DOI":"10.1016\/j.bbadis.2020.165720","volume":"1866","author":"SM Houten","year":"2020","unstructured":"Houten, S. M., Wanders, R. J. & Ranea-Robles, P. Metabolic interactions between peroxisomes and mitochondria with a special focus on acylcarnitine metabolism. Biochim. Biophys. Acta Mol. Basis Dis. 1866, 165720. https:\/\/doi.org\/10.1016\/j.bbadis.2020.165720 (2020).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"52309_CR40","doi-asserted-by":"publisher","first-page":"892","DOI":"10.3390\/biology13110892","volume":"13","author":"Y Duan","year":"2024","unstructured":"Duan, Y. et al. The role of the CPT family in cancer: searching for new therapeutic strategies. Biology 13, 892. https:\/\/doi.org\/10.3390\/biology13110892 (2024).","journal-title":"Biology"},{"key":"52309_CR41","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/mas.21510","volume":"37","author":"R Bandu","year":"2018","unstructured":"Bandu, R., Mok, H. J. & Kim, K. P. Phospholipids as cancer biomarkers: mass spectrometry-based analysis. Mass. Spectrom. Rev. 37, 107\u2013138. https:\/\/doi.org\/10.1002\/mas.21510 (2018).","journal-title":"Mass. Spectrom. Rev."},{"key":"52309_CR42","first-page":"8941","volume":"11","author":"C Shi","year":"2018","unstructured":"Shi, C., Qiao, S., Wang, S., Wu, T. & Ji, G. Recent progress of lysophosphatidylcholine acyltransferases in metabolic disease and cancer. Int. J. Clin. Exp. Med. 11, 8941\u20138953 (2018). https:\/\/www.ijcem.com\/files\/ijcem0072481.pdf\u200b","journal-title":"Int. J. Clin. Exp. Med."},{"key":"52309_CR43","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.3390\/cancers16112115","volume":"16","author":"J Korbecki","year":"2024","unstructured":"Korbecki, J. et al. Phospholipid acyltransferases: characterization and involvement of the enzymes in metabolic and cancer diseases. Cancers 16, 2115. https:\/\/doi.org\/10.3390\/cancers16112115 (2024).","journal-title":"Cancers"},{"key":"52309_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-017-0525-1","volume":"36","author":"Y Du","year":"2017","unstructured":"Du, Y. et al. Lysophosphatidylcholine acyltransferase 1 upregulation and concomitant phospholipid alterations in clear cell renal cell carcinoma. J. Exp. Clin. Cancer Res. 36, 1\u201311. https:\/\/doi.org\/10.1186\/s13046-017-0525-1 (2017).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"52309_CR45","doi-asserted-by":"publisher","first-page":"e4112","DOI":"10.1002\/nbm.4112","volume":"32","author":"K Sonkar","year":"2019","unstructured":"Sonkar, K. et al. Focus on the glycerophosphocholine pathway in choline phospholipid metabolism of cancer. NMR Biomed. 32, e4112. https:\/\/doi.org\/10.1002\/nbm.4112 (2019).","journal-title":"NMR Biomed."},{"key":"52309_CR46","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3389\/fonc.2016.00266","volume":"6","author":"M Cheng","year":"2016","unstructured":"Cheng, M., Bhujwalla, Z. M. & Glunde, K. Targeting phospholipid metabolism in cancer. Front. Oncol. 6, 266. https:\/\/doi.org\/10.3389\/fonc.2016.00266 (2016).","journal-title":"Front. Oncol."},{"key":"52309_CR47","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s13058-023-01742-0","volume":"25","author":"Z Tan","year":"2023","unstructured":"Tan, Z. et al. Key regulator PNPLA8 drives phospholipid reprogramming induced proliferation and migration in triple-negative breast cancer. Breast Cancer Res. 25, 148. https:\/\/doi.org\/10.1186\/s13058-023-01742-0 (2023).","journal-title":"Breast Cancer Res."},{"key":"52309_CR48","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41389-022-00420-8","volume":"11","author":"S Vasseur","year":"2022","unstructured":"Vasseur, S. & Guillaumond, F. Lipids in cancer: a global view of the contribution of lipid pathways to metastatic formation and treatment resistance. Oncogenesis 11, 46. https:\/\/doi.org\/10.1038\/s41389-022-00420-8 (2022).","journal-title":"Oncogenesis"},{"key":"52309_CR49","doi-asserted-by":"publisher","first-page":"6599","DOI":"10.7150\/jca.33024","volume":"10","author":"Z Zhao","year":"2019","unstructured":"Zhao, Z. et al. The mRNA expression signature and prognostic analysis of multiple fatty acid metabolic enzymes in clear cell renal cell carcinoma. J. Cancer. 10, 6599. https:\/\/doi.org\/10.7150\/jca.33024 (2019).","journal-title":"J. Cancer"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52309-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52309-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52309-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T23:51:13Z","timestamp":1783900273000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52309-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["52309"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-52309-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"assertion":[{"value":"3 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This research has led to the registration and filing of the following patents: Biomarker composition containing acylcarnitine metabolite for diagnosis of oral cancer (Korean Patent No. 10-2627818-00-00, European Patent Application No. 22816433.1, and U.S. Patent Application No. 18\/566,404).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patent applications"}}],"article-number":"21757"}}